| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:185-193.)
© 2005 American Heart Association, Inc.
Epidemiology |
From the Department of Clinical Biochemistry, Herlev University Hospital (C.E., B.G.N.), Department of Clinical Biochemistry (A.T.-H.), and Department of Cardiology (P.G.), Rigshospitalet, Copenhagen University Hospital, and The Copenhagen City Heart Study, Bispebjerg University Hospital (A.T.-H., M.A., B.G.N.), University of Copenhagen, Copenhagen, Denmark.
Correspondence to Børge G. Nordestgaard, MD, DMSc, Department of Clinical Biochemistry, Herlev University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark. E-mail brno{at}herlevhosp.kbhamt.dk
Received July 29, 2004; revision received March 11, 2005; accepted March 29, 2005.
Background We tested the hypothesis that the hereditary hemochromatosis genotypes C282Y/C282Y, C282Y/H63D, or C282Y/wild-type are risk factors for ischemic heart disease (IHD) and myocardial infarction (MI).
Methods and Results We performed a prospective study of 9178 individuals from the Danish general population followed up for 24 years, during which 1035 and 511 developed IHD and MI, respectively, and a case-control study of 2441 and 1113 IHD and MI cases versus 8080 controls. C282Y/C282Y, C282Y/H63D, and C282Y/wild-type versus wild-type/wild-type individuals were not associated with increased risk of IHD or MI in prospective studies, overall or stratified by gender. We had 90% power to detect a hazard ratio for IHD of 3.4 for C282Y/C282Y, 1.9 for C282Y/H63D, and 1.3 for C282Y/wild-type versus wild-type/wild-type. Furthermore, these genotypes were not associated with increased risk of IHD or MI in case-control studies, overall or stratified by gender. We had 90% power to detect an odds ratio for IHD of 3.6 for C282Y/C282Y, 1.8 for C282Y/H63D, and 1.3 for C282Y/wild-type versus wild-type/wild-type.
Conclusions In these studies, hereditary hemochromatosis C282Y/C282Y, C282Y/H63D, and C282Y/wild-type genotypes were not associated with IHD or MI; however, the study lacked the power to exclude the possibility that C282Y/C282Y and C282Y/H63D individuals have a modestly increased risk of IHD or MI.
Key Words: cardiovascular diseases prospective studies case-control studies hemochromatosis
Related Article:
Circulation 2005 112: 147.
This article has been cited by other articles:
![]() |
P. C. Adams, J. S. Pankow, J. C. Barton, R. T. Acton, C. Leiendecker-Foster, G. D. McLaren, M. Speechley, and J. H. Eckfeldt HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol: The Hemochromatosis and Iron Overload Screening Study Circ Cardiovasc Genet, February 1, 2009; 2(1): 34 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ellervik, A. Tybjaerg-Hansen, M. Appleyard, H. Sillesen, G. Boysen, and B. G. Nordestgaard Hereditary hemochromatosis genotypes and risk of ischemic stroke Neurology, March 27, 2007; 68(13): 1025 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Hu The Iron-Heart Hypothesis: Search for the Ironclad Evidence JAMA, February 14, 2007; 297(6): 639 - 641. [Full Text] [PDF] |
||||
![]() |
S. Goland, S. D. Malnick, C. Ellervik, B. G. Nordestgaard, A. Tybjaerg-Hansen, P. Grande, A. Tybjaerg-Hansen, M. Appleyard, and B. G. Nordestgaard Letter Regarding Article by Ellervik et al, "Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study" * Response Circulation, January 3, 2006; 113(1): e10 - e10. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |